Learn more about clinical trials
Participation in a Clinical Trial
Once you decide that a clinical trial may be right for you, understanding what participation involves can help you feel prepared and confident. This page explains what to expect during a clinical trial, your rights as a participant, and the supports available to you.
What participation may involve
Participation in a clinical trial can look different depending on the study. Some trials involve frequent visits and testing, while others require minimal involvement.
Depending on the study, participation may include:
- Clinic or hospital visits
- Physical exams or imaging
- Blood tests or other lab work
- Questionnaires about symptoms or quality of life
- Taking a study medication or following a specific care plan
Some trials require travel to a specialized center, while others allow partial or fully remote participation. The study team will explain what is required before you decide to enroll.
Informed Consent
Before joining a clinical trial, you will be asked to review and sign an informed consent document. This document explains:
- The purpose of the study
- What participation involves
- Possible risks and benefits
- How your information will be used and protected
Informed consent is not just a form—it is a process. You have the right to ask questions, take time to review the information, and discuss it with your healthcare team or family before making a decision.
Your Rights as a Participant
As a clinical trial participant, you have important rights. These include:
- Participation is voluntary
- You may choose not to join or to leave a study at any time
- Leaving a study will not affect your standard medical care
- You have the right to ask questions and receive clear answers
- Your privacy and personal health information are protected
You remain in control of your care throughout the study.
Potential Benefits and Risks
Clinical trials may offer potential benefits, such as access to new treatments or closer medical monitoring. However, benefits are not guaranteed, and outcomes can vary from person to person.
There may also be risks, including side effects or unknown responses to a treatment. The study team will explain known risks and what is being done to monitor safety.
Deciding to participate means weighing possible benefits and risks based on your individual situation, values, and goals.
Support During a Clinical Trial
You are not alone during a clinical trial. Support may come from:
- Your primary healthcare team
- The clinical trial study team or coordinator
- Family members or caregivers
LGDA does not recommend specific clinical trials, but we are committed to providing education and trusted information to help patients and families understand the clinical trial process and prepare questions for their care team.
If You Have Questions
It is normal to have questions or concerns before, during, or after participation in a clinical trial. If something is unclear, you should feel comfortable asking your healthcare provider or study team for more information.
Taking part in a clinical trial is a personal decision. The right choice is the one that feels best for you and your family.
Discover current clinical trials, registry studies, and research surveys focused on isolated lymphatic malformations and complex lymphatic anomalies. Use these resources to learn about emerging treatments and discuss potential opportunities with your healthcare provider.
STARBORN-1 Study:
This medical research study is at children's hospitals and clinics in the US and focused on the cyst in lymphatic malformations. Visit the study website, download informational flyer, or visit clinical trials website.
PTX-022 in the Treatment of Microcystic Lymphatic Malformations:
This study is to assess the change in microcystic lymphatic malformations IGA with QTORIN™ 3.9% Rapamycin Anhydrous Gel. This study has 15 locations around the US. Questions - See complete information.
Interview Survey about Vascular Malformations:
This research study is specifically looking for those with Lymphatic Malformations and PIK3CA-Related Overgrowth Spectrum. The survey is limited to the US. See complete information. (PDF)
Alpelisib in PIK3CA Associated Lymphatic Malformations:
This study is to evaluate the safety and efficacy of a drug called alpelisib in patients diagnosed with lymphatic malformations, with confirmed PIK3CA variant. See complete information.
A Prospective Natural History Study of Lymphatic Anomalies:
Find out more about the study and the eligibility criteria.
Zovegalisib (RLY-2608) Clinical Trial for PIK3CA-Related Vascular Anomalies:
Researchers are evaluating the safety of the treatment and whether it may help improve symptoms caused by these rare conditions. This is a worldwide study. See complete information
We recommend that you seek the guidance of your physician when making decisions regarding research or entering a clinical trial. This information is a resource only and the Lymphatic Malformation Alliance receives no support or compensation for the listing of research programs/clinical trials.
